The Prime Minister will call on world leaders to back efforts to speed up the development of new vaccines, treatments and tests at a G7 meeting.
- Slashing the time to develop vaccines for new diseases to 100 days will save countless lives in future health crises
- UK confirms it will send the majority of any future surplus vaccines to the COVAX scheme to support developing countries
The Prime Minister is setting out his ambition today to cut the time to develop new vaccines by two-thirds to 100 days, as he chairs the first G7 leaders’ meeting of the UK’s presidency.
He has asked Sir Patrick Vallance to work with international partners, including the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI), as well as industry and scientific experts to advise the G7 on speeding up the process for developing vaccines, treatments and tests for common pathogens.
The development of a coronavirus vaccine in approximately 300 days was a huge and unprecedented global achievement. By reducing the time to develop new vaccines for emerging diseases even further, we may be able to prevent the catastrophic health, economic and social repercussions seen in this crisis. The 100 day ambition was proposed by CEPI earlier this year.
Through international collaboration to intensify research and development, modernise medical trials and create more innovative vaccine manufacturing and supply chains, we can save lives in future health crises and prevent the next pandemic.
The Prime Minister has also confirmed today that the UK will share the majority of any future surplus coronavirus vaccines from our supply with the COVAX procurement pool to support developing countries, in addition to the UK’s £548 million funding for the scheme. He will be encouraging G7 leaders to increase their funding for COVAX in support of equitable access to vaccines.
Speaking ahead of today’s meeting, the Prime Minister Boris Johnson said:
Perhaps more than ever, the hopes of the world rest on the shoulders of scientists and over the last year, like countless times before, they have risen to the challenge.
The development of viable coronavirus vaccines offers the tantalising prospect of a return to normality, but we must not rest on our laurels. As leaders of the G7 we must say today: never again.
By harnessing our collective ingenuity, we can ensure we have the vaccines, treatments and tests to be battle-ready for future health threats, as we beat Covid-19 and build back better together.
